Physician profile
Paul B Bernstein
NPI 1932102688
$2,368.52
in general payments reported to CMS, 2019-2025
20 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Sports Medicine (Podiatrist) provider received nationally (typical 2025 total: $307).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $472 · 2021: $21.90 · 2022: $398 · 2023: $295 · 2024: $248 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $248.86 | 2019-2020 | |
| Wright Medical Technology, INC. | $243.96 | 2019 | |
| Medtronic Vascular, INC. | $239.12 | 2019-2020 | |
| Nevro Corp. | $196.28 | 2022-2023 | Senza |
| Orthofix Medical, INC. | $152.66 | 2020 | |
| Bioventus LLC | $147.26 | 2023 | |
| Treace Medical Concepts, INC. | $145.93 | 2024 | |
| Mimedx Group, INC. | $137.56 | 2025 | |
| Paratek Pharmaceuticals, INC. | $124.59 | 2022 | |
| Baxter Healthcare | $117.61 | 2019 | |
| Averitas Pharma INC. | $111.98 | 2023 | Qutenza |
| Celularity INC. | $110.41 | 2020 | |
| Zimmer Biomet Holdings, INC. | $110.29 | 2019 | |
| Organogenesis INC. | $102.31 | 2024 | Apligraf, Affinity, Nushield |
| Collegium Pharmaceutical, INC. | $46.37 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $44.86 | 2025 | Inceptiv |
| Alkermes, INC. | $37.58 | 2022 | |
| Depuy Synthes Sales INC. | $17.91 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.48 | 2022 | |
| Almatica Pharma LLC | $15.50 | 2023 | Gralise |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.